Home
About
Journal Issues
In Press
Video Article
Indexing and Citation Metrics
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
1735-403X
eISSN
:
2383-2886
Submit Your Paper
Editorial Board
Instructions for Authors
Instructions for Reviewers
Contact Us
Editorial Policies
Peer Review
Archive
Follower of ICMJE
Powered by:
Pharm Sci
. 2020;26(Covid-19): S52-S62. doi:
10.34172/PS.2020.44
Research Article
In Silico Drug Repurposing of Penicillins to Target Main Protease M
pro
of SARS-CoV-2
Baby Krishnaprasad
1
, Swastika Maity
1
, Chetan Mehta
2
, Akhil Suresh
2
, Usha Y Nayak
2
, Yogendra Nayak
1
*
Cited by CrossRef: 3
1- Velagacherla V, Suresh A, Mehta C, Nayak U, Nayak Y. Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment.
Viruses
. 2023;15(1):213
[Crossref]
2- Fadlalla M, Ahmed M, Ali M, Elshiekh A, Yousef B. Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models.
Curr Pharmacol Rep
. 2022;8(3):212
[Crossref]
3- Baby K, Maity S, Mehta C, Nayak U, Shenoy G, Pai K, Harikumar K, Nayak Y. Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer.
Sci Rep
. 2023;13(1)
[Crossref]
Indexing & Abstracting:
Follow us on LinkedIn
Follow us on Twitter